Lab Members Receive Research Poster Awards at National and International Conferences

Kelly Ho Receives Poster Award at World Muscle Society Congress

Congratulations to PhD researcher Kelly Ho, whose poster presentation “Investigating muscle specific kinase antibody treatment for Agrn and ColQ Congenital Myasthenia Syndromes” received one of the prestigious Elsevier runner up awards at the 2024 World Muscle Society congress in Prague, Czech Republic!

 

Dr Lola Lessard Receives Best Research Poster Award at Western Canadian Neuromuscular Conference

Congratulations to TOH fellow Dr Lola Lessard, whose poster presentation “Metabolic defects in Type 1 Myotonic Dystrophy: a potential therapeutic target” received the award for best research poster at the Western Canadian Neuromuscular Conference (WCNMC) research symposium this past September!

Dr Lola Lessard awarded best research poster at WCNMC

 

Ottawa Neuromuscular Fellows from TOH and CHEO Attended the Western Canadian Neuromuscular Conference

This past September 27-29, neuromuscular fellows from clinical training programs in Ottawa Drs Astrid Eisenkölbl, Lola Lessard and Joaquin Machado had the opportunity to attend the WCNMC in Calgary, AB. There, our fellows had a chance to meet and network with trainees and senior clinicians and researchers from the neuromuscular community, and attend the rich program of clinical practice and translational research updates.

Neuromuscular fellows from Ottawa at the WCNMC

Neuromuscular fellows from Ottawa at the Western Canadian Neuromuscular Conference in Calgary, AB

Dr Lola Lessard and Kelly Ho receive prestigious research poster awards

Read next...

Clinical trial update - Canadian Patient First in the World to Receive Trial Drug in Argenx DOK7-CMS Study

Canadian Patient Receives Trial Drug in Argenx DOK7-CMS Study

Our clinical research team at the NeuroMuscular centre of The Ottawa Hospital is excited to share that a Canadian patient affected by DOK-7 Congenital Myasthenic...
New lab publication - Brain malformations and seizures by impaired chaperonin function of TRiC

New Publication: Brain malformations and seizures by impaired chaperonin function of TRiC

We are excited to share a new publication from our research team! The study “Brain malformations and seizures by impaired chaperonin function of TRiC” uncovers...
New leadership for the University of Ottawa Centre for Neuromuscular Disease, Drs Mireille Khacho and Hanns Lochmuller.

Drs Hanns Lochmüller and Mireille Khacho New Leaders of University of Ottawa Eric Poulin Centre for Neuromuscular Disease

We are delighted to share exciting news from the uOttawa Brain and Mind Research Institute (uOBMRI)! Drs. Hanns Lochmüller and Mireille Khacho have been appointed...
Clinical trial updates in FSHD

FSHD Clinical Trial Updates

Two clinical trial opportunities in FSHD at The Ottawa NeuroMuscular Centre now recruiting, FSHD community receive negative topline results from phase 3 losmapimod (REACH) trial....
Lessard-funding-DM1_1200x900 (1)

Dr. Lola Lessard Receives Postdoctoral Fellowship to study AMPK signaling in DM1

We are excited to share that  Dr. Lola Lessard has been awarded a one-year postdoctoral research fellowship from AFM-Téléthon to study AMP-activated protein kinase (AMPK)...
Congratulations to the 2024 Lochmuller Lab graduates, Emily Freeman and Catherine Choueiri.

Congratulations to the Lab’s Recent Graduates!

The Lochmüller Lab would like to congratulate two of our members on graduating from PhD and MSc programs at the University of Ottawa this past...